12 results found.

Esophageal Cancer, Bile Duct Neoplasms, Gastric Cancer, Liver Can Clinical Trial

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Collection of Tissue, Blood and Other Specimens From Patients With Benign and Malignant Tumors of the Soft Tissue, Gastrointestinal Tract, and Other Intra-abdominal Sites..

Stomach Neoplasms; Esophageal Neoplasms; Metastatic Gastric Cance Clinical Trial using AUY922; BYL719

Novartis - Recruiting 18 years or older.
- A Phase IB, Multicenter, Open-label Dose Escalation Study of the PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric Cancer Carrying a Molecular Alteration of PIK3CA or an Amplification of HER2.
AUY922; BYL719

Colorectal Neoplasms, Esophageal Neoplasms, or Ovarian Neoplasms Clinical Trial using Indomethacin

UMC Utrecht - Recruiting 18 years to 70 years.
- Phase I Study Evaluating Indomethacin in Combination With Platinum-based Chemotherapy.
Indomethacin

Stomach Neoplasms Clinical Trial using AMG 337

Amgen - Recruiting 18 years or older.
- A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors.
AMG 337

Lung Cancer, Esophageal Cancer, Mesothelioma, Gastrointestinal Ne Clinical Trial using Mithramycin

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Phase II Evaluation of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum.
Mithramycin

Barrett's Esophagus, or Esophageal Neoplasms Clinical Trial using Radiofrequency Ablation(RFA) by HALO device.; Endoscopic mucosal resection(EMR) by mucosectomy kit.

Midwest Biomedical Research Foundation - Recruiting 18 years or older.
- Endoscopic Resection or Ablation for Patients With Dysplasia or Intramucosal Cancer in Barrett's Esophagus.
Radiofrequency Ablation(RFA) by HALO device.; Endoscopic mucosal resection(EMR) by mucosectomy kit.

Esophageal Fistula, Esophageal Neoplasms, Esophageal Perforation, Clinical Trial using Evolutionr Esophageal Stent - Fully Covered

Cook - Recruiting 18 years or older.
- Clinical Investigation to Evaluate Removal of the Evolutionr Esophageal Stent - Fully Covered.
Evolutionr Esophageal Stent - Fully Covered

Esophageal Neoplasms, Adenocarcinoma of the Gastroesophageal Junc Clinical Trial using DKN-01; Paclitaxel

Dekkun Corporation - Recruiting 30 years or older.
- A Two Part, Phase 1, Multi-Center, Open-Label Study of DKN-01 in Combination With Weekly Paclitaxel in Patients With Relapsed or Refractory Esophageal Cancer or Gastro-Esophageal Junction Tumors.
DKN-01; Paclitaxel

Esophageal Neoplasms Clinical Trial using Pronase; Control No pronase plus Dimethicone and sodium bicarbonate

Xijing Hospital of Digestive Diseases - Recruiting 18 years to 75 years.
- .
Pronase; Control No pronase plus Dimethicone and sodium bicarbonate

Esophageal Cancer, Esophageal Dysplasia, Stomach Cancer, or Stoma Clinical Trial using Hybrid knife; IT knife

Xijing Hospital of Digestive Diseases - Recruiting 18 years to 80 years.
- Comparison of O-type Hybrid Knife and IT Knife in Endoscopic Submucosal Dissection for Upper Gastrointestinal Neoplasms: a Prospective Randomized Controlled Trial.
Hybrid knife; IT knife

Esophageal Neoplasms Clinical Trial

Maastricht Radiation Oncology - Recruiting 18 years or older.
- Consequences of Positron-Emission-Tomography/Computed Tomography (PET/CT) Based Radiotherapy Treatment Planning for Clinical Outcome in Esophageal Cancer Patients.

Esophageal Neoplasms, or Stomach Neoplasms Clinical Trial using Docetaxel, Oxaliplatin; Radiotherapy

Johannes Gutenberg University Mainz - Recruiting 18 years to 75 years.
- Prospective, Open, Multicentre Phase I/II Study to Evaluate the Safety and Efficacy of a Neoadjuvant Radiochemotherapy With Docetaxel and Oxalipaltin in Patients With Adenocarcinoma of the Gastric-Oesophageal Junction.
Docetaxel, Oxaliplatin; Radiotherapy